[Federal Register Volume 60, Number 233 (Tuesday, December 5, 1995)]
[Notices]
[Pages 62251-62253]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-29558]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
[INFO-95-07]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 639-3453.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques for other 
forms of information technology. Send comments to Wilma Johnson, CDC 
Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA 
30333. Written comments should be received within 60 days of this 
notice.

Proposed Projects

    1. Resources and Services Database of the CDC National AIDS 
Clearinghouse (NAC)--(0920-0255)--Extension--This is a request to 
extend this project for three years. NAC will mail the Resource 
Organization Questionnaire along with a cover letter once an 
organization is identified as providing AIDS-related services. Each 
organization will also receive a stamped, self-addressed envelope for 
the return of the questionnaire. If there is no response a follow-up 
letter will be sent along with another questionnaire and return 
envelope. A telephone call will be made to those organizations who 
respond but whose responses need clarification. Approximately one third 
of the entire Resources and Services Database is verified each year. As 
part of this process, 40 percent of these organizations will receive a 
copy of their current database entry by mail, including a cover letter, 
a list of instructions, and a stamped, self-addressed envelope. The 
remaining 60 percent will receive a telephone call to review their 
record.
    The Centers for Disease Control and Prevention (CDC) National AIDS 
Clearinghouse (NAC), is a critical member of the network of government 
agencies, community organizations, businesses, health professionals, 
educators, and human services providers that educate the American 
public about Acquired immunodeficiency syndrome (AIDS) and provide 
services for persons infected with human immunodeficiency virus (HIV). 
NAC's Resources and Services Database contains records of approximately 
18,000 organizations and is the most comprehensive listing of AIDS 
resources and services available throughout the country.
    NAC's reference staff rely on the Resources and Services Database 
to respond to more than 100,000 requests for information or referral 
each year. The Database is also the main information source for the CDC 
National AIDS Hotline which refers approximately 1.8 million callers 
from the general public each year to appropriate organizations for 
information, services, and treatment.
    In its continuing efforts to maintain an up-to-date, comprehensive 
database, NAC is seeking renewal of approval of the survey instrument 
and proposed methods. The total cost to respondents is estimated at 
$94,466.00.

------------------------------------------------------------------------
                                                         Avg.           
                                             No. of     burden/   Total 
         Respondents             No. of    responses/  response   burden
                              respondents  respondent     (in      (in  
                                                         hrs.)    hrs.) 
------------------------------------------------------------------------
Questionnaire...............      2,400            1       0.33      800
Clarification follow-up.....        360            1       0.17       60
Verification................     10,636            1       0.33     3545
Verif. follow-up............        993            1       0.17      166
Total.......................  ...........  ..........  ........     3771
------------------------------------------------------------------------

    2. Evaluation of a Training Curriculum for Hemophilia Nurses Who 
Teach Home Infusion and Infection Control--New--The Hematologic 
Disorders Branch at CDC has plans to develop, pilot, and evaluate 
training curricula for hemophilia health care providers to improve 
their knowledge and skills in teaching home infusion of 

[[Page 62252]]
Factors VII and IX (coagulating agents which reduce the bleeding 
resulting from a deciciency of natural clotting agents in the blood of 
people with hemophilia) and infection control related to the infusion. 
CDC has initiated the development of a self-learning manual for nurses 
with responsibility of teaching hemophilia patients and their families 
about home infusion and infection control (HI/IC). The goals of the 
manual are (1) to facilitate nurses' understanding of content that 
should be covered when teaching HI/IC techniques, and (2) to assist 
nurses in determining how they can best teach HI/IC to patients and 
their families. The purpose of the proposed data collection is to 
assess the efficacy of the manual in achieving those goals.
    An experimental design will be employed in this study in which 100 
randomly sampled nurses will be assigned to either an experimental 
condition (n=50) or to a control group (n=50). Nurses in the 
experimental condition will be asked to use the manual, while those in 
the control condition will continue their current practices and engage 
in any naturally-occuring learning experiences related to HI/IC. 
Baseline and follow-up surveys administered to both groups will yield 
data that will be used to determined the difference in knowledge, 
attitudes, and skills that can be attributed to use of the self-
learning guide.

------------------------------------------------------------------------
                                                         Avg.           
                                             No. of     burden/   Total 
         Respondents             No. of    responses/  response   burden
                              respondents  respondent     (in      (in  
                                                         hrs.)    hrs.) 
------------------------------------------------------------------------
Nurses in experimental                                                  
 condition..................         50            2       0.50       50
Nurses in control condition.         50            2       0.50       50
  Total.....................  ...........  ..........  ........      100
------------------------------------------------------------------------

    3. Complications Associated with Home Infusion Therapy: The Nature 
and Frequency of Blood Contacts Among Health Care Workers--NEW--
Occupational blood contact and the potential for transmission of 
bloodborne pathogens is a serious concern for health care workers 
(HCWs) who provide care to patients. There are no data on the frequency 
of occupational percutaneous injuries and mucocutaneous blood contact 
among HCWs who provide home infusion therapy.
    The Hospital Infections Program, National Center for Infectious 
Diseases, will conduct prospective, active surveillance of HCWs who 
provide home infusion therapy. The objectives of the surveillance 
project are to (1) estimate the procedure-specific frequency of and 
assess risk factors for percutaneous, mucous membrane, or cutaneous 
blood contacts sustained by HCWS during the delivery of home infusion 
therapy and the performance of related procedures, such as phlebotomy 
and blood culture collection; (2) describe and evaluate the 
effectiveness of infection control precautions and safety devices to 
prevent blood contacts; and (3) evaluate the impact of HCWs' knowledge 
of universal precautions on the use of protective equipment, safety 
devices, and the frequency of blood contacts.
    The population under surveillance will be nurses and phlebotomists 
from three home health care agencies. Before beginning data collection, 
HCWs will complete a background questionnaire to provide basic 
demographic information as well as information about previous blood 
contacts. HCWs will then complete an exposure questionnaire after each 
home visit for a two-four week data collection period. This 
questionnaire will include information about the reason for the visit, 
the types of procedures performed, the length of the visit, the number 
and types of blood contacts sustained, and the use of infection control 
precautions and any safety devices. At the end of their individual data 
collection period, each HCW will complete an infection control 
questionnaire to assess knowledge and attitudes related to blood 
contacts and the use of universal precautions. The total cost to 
respondents is estimated at $24,633.

------------------------------------------------------------------------
                                                         Avg.           
                                             No. of     burden/         
     Respondents (HCWs)          No. of    responses/  response   Total 
                              respondents  respondent     (in     burden
                                                         hrs.)          
------------------------------------------------------------------------
Background questionnaire....       1337            1       .083      111
Exposure questionnaire......       1337           41      .0167      915
Infection control                                                       
 questionnaire..............       1337            1       .083      111
  Total.....................  ...........  ..........  ........     1137
------------------------------------------------------------------------

    4. Surveillance and Epidemiology Study Core Questionnaire and 
Supplement Modules--(0923-0010)--Revision--ATSDR is revising and 
renewing the project which follows populations exposed to specific 
hazardous substances over a period of time to determine if they are 
experiencing elevated occurrence of diseases. In addition to 
demographic information, additional core information is collected on 
behavioral characteristics and health conditions. The supplemental 
modules are also included in the request that may be used, depending on 
the organ system targeted or the type of respondent (renal, liver, 
occupational, respiratory, etc). The total cost to respondents is 
estimated at $53,153.64.

                                                                        

[[Page 62253]]
----------------------------------------------------------------------------------------------------------------
                                                                                                 Avg.     Total 
                                                                        No. of      No. of     burden/    burden
                            Respondents                              Respondents  responses/  responses    (in  
                                                                                  respondent  (in hrs.)   hrs.) 
----------------------------------------------------------------------------------------------------------------
Households.........................................................       2667            7       .369      4908
----------------------------------------------------------------------------------------------------------------



    Dated: November 29, 1995.
Wilma G. Johnson,
Acting Associate Director for Policy Planning And Evaluation, Centers 
for Disease Control and Prevention (CDC).
[FR Doc. 95-29558 Filed 12-4-95; 8:45 am]
BILLING CODE 4163-18-P